Transfusion therapy resident survival guide: Difference between revisions
Line 19: | Line 19: | ||
|[[red blood cell|Packed red blood cells]] (PRBC) | |[[red blood cell|Packed red blood cells]] (PRBC) | ||
|❑ [[Bleeding|Acute hemorrhage]] <br>❑ To ↑ O<sub>2</sub>-carrying capacity of blood in cases of end-organ [[ischemia]] | |❑ [[Bleeding|Acute hemorrhage]] <br>❑ To ↑ O<sub>2</sub>-carrying capacity of blood in cases of end-organ [[ischemia]] | ||
| 1 unit of PRBC = ↑ [[Hemoglobin]] (Hb) concentration by 1 g/dL<br>''' | | 1 unit of PRBC = ↑ [[Hemoglobin]] (Hb) concentration by 1 g/dL<br>Transfuse slowly for the first 15 minutes<br>'''Complete transfuse within 4 hours'''. | ||
|- | |- | ||
|[[Platelets]] (Plts) | |[[Platelets]] (Plts) | ||
|In patients with [[thrombocytopenia]] (plts < 150,000 cells/uL)<br>❑ For prophylaxis (to prevent [[bleeding]]) <br>❑ For treatment (during active bleeding)<br> '''Contraindications'''<br>❑ [[Thrombotic thrombocytopenic purpura|TTP]]/[[Hemolytic-uremic syndrome|HUS]], [[Heparin-induced thrombocytopenia|HIT]], [[HELLP syndrome]]<br>Click [[Thrombocytopenia resident survival guide#Indications for Platelet Transfusion in Thrombocytopenia|here]] for more information. | |In patients with [[thrombocytopenia]] (plts < 150,000 cells/uL)<br>❑ For prophylaxis (to prevent [[bleeding]]) <br>❑ For treatment (during active bleeding)<br> '''Contraindications'''<br>❑ [[Thrombotic thrombocytopenic purpura|TTP]]/[[Hemolytic-uremic syndrome|HUS]], [[Heparin-induced thrombocytopenia|HIT]], [[HELLP syndrome]]<br>Click [[Thrombocytopenia resident survival guide#Indications for Platelet Transfusion in Thrombocytopenia|here]] for more information. | ||
| | |1 apheresis product = 6 units of plts in 250 - 300 mls of plasma<br>1 dose of apheresis product = ↑ plt count by 30,000 - 60,000/uL | ||
|- | |- | ||
|[[Fresh frozen plasma]] | |[[Fresh frozen plasma]] |
Revision as of 17:46, 13 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Overview
Blood transfusion is the process of transferring blood or blood products obtained from one person (donor) into the circulatory system of another (recipient).
Massive blood transfusion refers to transfusing a large volume of blood to a patient, especially in trauma patients with uncontrollable hemorrhage. Several definitions used in the past include:
- Transfusion of 20 units of red blood cells (RBCs) in 24 hours.[1]
- Transfusion of greater than 10 units of RBCs in 24 hours.[2]
Currently, it is more practical to identify patients in need of massive transfusion when greater than four red blood cell units is needed in one hour and an ongoing need for transfusion is predicted,[3] or when 50% of total blood volume is replaced within 3 hours. These situations often require the activation of massive transfusion protocols (MTP).[4]
Blood Products and Indications for Use
Blood Products | Indications | Dose |
---|---|---|
Packed red blood cells (PRBC) | ❑ Acute hemorrhage ❑ To ↑ O2-carrying capacity of blood in cases of end-organ ischemia |
1 unit of PRBC = ↑ Hemoglobin (Hb) concentration by 1 g/dL Transfuse slowly for the first 15 minutes Complete transfuse within 4 hours. |
Platelets (Plts) | In patients with thrombocytopenia (plts < 150,000 cells/uL) ❑ For prophylaxis (to prevent bleeding) ❑ For treatment (during active bleeding) Contraindications ❑ TTP/HUS, HIT, HELLP syndrome Click here for more information. |
1 apheresis product = 6 units of plts in 250 - 300 mls of plasma 1 dose of apheresis product = ↑ plt count by 30,000 - 60,000/uL |
Fresh frozen plasma | ||
Cryoprecipitate | ||
Immunoglobulins | ||
Albumin | ||
Irradiated | ||
Cytomegalovirus-negative | ||
Leuko-reduced |
Management
General Approach
Characterize the symptoms: ❑ Low red blood cell count or low hemoglobin level
❑ Low white blood cell count
❑ Low platelet count
| |||||||||||||||||||||||||||||
Obtain a detailed history: -❑ Review medical records
| |||||||||||||||||||||||||||||
Examine the patient: ❑ | |||||||||||||||||||||||||||||
Order laboratory tests: ❑ | |||||||||||||||||||||||||||||
Pre-transfusion preparation: ❑ | |||||||||||||||||||||||||||||
Low hemoglobin level | Coagulopathy | ||||||||||||||||||||||||||||
Low platelets | Coagulation factor deficiency | ||||||||||||||||||||||||||||
Indications | Indications | Indications | |||||||||||||||||||||||||||
Consider fresh frozen plasma | Consider cryoprepitate | Consider prothrombin complex concentrate | |||||||||||||||||||||||||||
Packed Red Blood Cells
Low hemoglobin concentration: ❑ | |||||||||||||||||||||||||||||||||||||||||
Review indications to transfuse: ❑ | |||||||||||||||||||||||||||||||||||||||||
Actively bleeding: ❑ Frank bleeding
❑ Occult bleeding
| |||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||
Asymtomatic | Symptomatic: ❑ | Symptomatic: ❑ | Asymptomatic | ||||||||||||||||||||||||||||||||||||||
Treat | Transfuse packed red blood cells | Treat | |||||||||||||||||||||||||||||||||||||||
Monitoring: ❑ | Manage complications: ❑ | Treat underlying cause: ❑ | |||||||||||||||||||||||||||||||||||||||
Managing Complications
Do's
Don'ts
References
- ↑ Wudel JH, Morris JA, Yates K, Wilson A, Bass SM (1991). "Massive transfusion: outcome in blunt trauma patients". J Trauma. 31 (1): 1–7. PMID 1986111.
- ↑ Malone DL, Hess JR, Fingerhut A (2006). "Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol". J Trauma. 60 (6 Suppl): S91–6. doi:10.1097/01.ta.0000199549.80731.e6. PMID 16763487.
- ↑ Moltzan CJ, Anderson DA, Callum J, Fremes S, Hume H, Mazer CD; et al. (2008). "The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework". Transfus Med. 18 (2): 112–20. doi:10.1111/j.1365-3148.2008.00846.x. PMID 18399845.
- ↑ Sihler KC, Napolitano LM (2009). "Massive transfusion: new insights". Chest. 136 (6): 1654–67. doi:10.1378/chest.09-0251. PMID 19995767.